MYC and cancer: SLC1A5 has long been a focus of investigation in cancer pathophysiology, where it is noted to be upregulated in numerous cancer cell lines by metabolic transcriptional regulators such as c-MYC and the kinase mTOR, which governs cancer cell proliferation, growth, and survival [14,15,16,17,18,19].